1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Other Events
Director Elections and Executive Compensation Approved at Annual Meeting
To Acquire Vega Therapeutics, a Wholly Owned Subsidiary, Expanding its Hematology Portfolio into Bleeding Disorders
Annual Report to Security Holders
Results of Operations and Financial Condition
Director Resignation - Susanne Schaffert Steps Down from Board
Announces Executive Leadership Appointments
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Tender Offer Statement by Issuer
SC TO-I
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
Submission Upload
Correspondence